Integrated Proteins Ltd Board Meeting on Nov 5 to Discuss Q2 Results

Integrated Proteins Ltd has announced that its Board of Directors will convene on November 5, 2026. The primary agenda item is to consider and approve the unaudited financial results for the quarter and half-year ended September 30, 2026, along with the accompanying Limited Review Report. Additionally, any other business tabled for discussion will be addressed. The company also stated that the trading window, closed since September 1, 2026, will reopen 48 hours after the financial results are declared, specifically on November 7, 2026.